Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes

Identification of biomarkers that predict responses to hypomethylating agents (HMAs) will allow optimal strategies for epigenetic therapy in myelodysplastic syndromes (MDS) to be established. Serum miR-21 was quantitatively measured in 58 MDS patients treated with HMAs and 14 healthy controls. Serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yundeok, Cheong, June-Won, Kim, Yeo-Kyeoung, Eom, Ju-In, Jeung, Hoi-Kyung, Kim, Soo Jeong, Hwang, Dohyu, Kim, Jin Seok, Kim, Hyeuong Joon, Min, Yoo Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913572/
https://www.ncbi.nlm.nih.gov/pubmed/24503739
http://dx.doi.org/10.1371/journal.pone.0086933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913572/
https://www.ncbi.nlm.nih.gov/pubmed/24503739
http://dx.doi.org/10.1371/journal.pone.0086933

Ejemplares similares